JT Stratford LLC’s Amedisys AMED Stock Holding History

JT Stratford LLC’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,582	Closed	-$1.21M	–	293
2024 Q3	$1.21M	Sell	12,582 -6,263	-33%	-$611K	0.21%	119
2024 Q2	$1.73M	Sell	18,845 -2,573	-12%	-$239K	0.32%	71
2024 Q1	$1.97M	Sell	21,418 -1,178	-5%	-$110K	0.39%	62
2023 Q4	$2.15M	Buy	+22,596	New	+$2.11M	0.49%	47
2022 Q2	–	Sell	-1,627	Closed	-$280K	–	211
2022 Q1	$280K	Buy	+1,627	New	+$243K	0.08%	170

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

JT Stratford LLC's AMED Position: Q4 2024 in Review

JT Stratford LLC sold out of Amedisys (AMED) in Q4 2024, closing a stake of 12,582 shares — an estimated $1.21M sold.

JT Stratford LLC first reported a position in AMED in Q1 2022 and held it in 5 quarters. The position peaked at $2.15M in Q4 2023. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

JT Stratford LLC reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
JT Stratford LLC sold 12,582 Amedisys shares in Q4 2024, an estimated $1.21M.
JT Stratford LLC first reported a position in Amedisys in Q1 2022 and held it in 5 quarters.
JT Stratford LLC's Amedisys position peaked at $2.15M in Q4 2023.
290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on JT Stratford LLC's 13F filing for Q4 2024, filed 18 Feb 2025.